Kinase-Inhibitors in Iodine-Refractory Differentiated Thyroid Cancer—Focus on Occurrence, Mechanisms, and Management of Treatment-Related Hypertension

Differentiated thyroid cancer (DTC) usually has a good prognosis when treated conventionally with thyroidectomy, radioactive iodine (RAI) and thyroid-stimulating hormone suppression, but some tumors develop a resistance to RAI therapy, requiring alternative treatments. Sorafenib, lenvatinib and cabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaae, Anne Christine, Kreissl, Michael C., Krüger, Marcus, Infanger, Manfred, Grimm, Daniela, Wehland, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623313/
https://www.ncbi.nlm.nih.gov/pubmed/34830100
http://dx.doi.org/10.3390/ijms222212217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623313/
https://www.ncbi.nlm.nih.gov/pubmed/34830100
http://dx.doi.org/10.3390/ijms222212217

Ejemplares similares